- Home
- FBK vs SWTX Comparison
FBK vs SWTX Comparison
Compare FBK & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBK
- SWTX
- Stock Information
- Founded
- FBK 1906
- SWTX 2017
- Country
- FBK United States
- SWTX United States
- Employees
- FBK N/A
- SWTX N/A
- Industry
- FBK Major Banks
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- FBK Finance
- SWTX Health Care
- Exchange
- FBK Nasdaq
- SWTX Nasdaq
- Market Cap
- FBK 2.6B
- SWTX 2.2B
- IPO Year
- FBK 2016
- SWTX 2019
- Fundamental
- Price
- FBK $51.43
- SWTX $35.59
- Analyst Decision
- FBK Hold
- SWTX Strong Buy
- Analyst Count
- FBK 6
- SWTX 5
- Target Price
- FBK $48.67
- SWTX $67.00
- AVG Volume (30 Days)
- FBK 168.3K
- SWTX 1.1M
- Earning Date
- FBK 01-14-2025
- SWTX 11-12-2024
- Dividend Yield
- FBK 1.32%
- SWTX N/A
- EPS Growth
- FBK N/A
- SWTX N/A
- EPS
- FBK 2.30
- SWTX N/A
- Revenue
- FBK $436,397,000.00
- SWTX $135,487,000.00
- Revenue This Year
- FBK N/A
- SWTX $3,426.90
- Revenue Next Year
- FBK $10.45
- SWTX $88.92
- P/E Ratio
- FBK $22.40
- SWTX N/A
- Revenue Growth
- FBK N/A
- SWTX N/A
- 52 Week Low
- FBK $33.35
- SWTX $28.21
- 52 Week High
- FBK $58.88
- SWTX $53.92
- Technical
- Relative Strength Index (RSI)
- FBK 36.22
- SWTX 39.83
- Support Level
- FBK $50.83
- SWTX $34.36
- Resistance Level
- FBK $56.06
- SWTX $42.51
- Average True Range (ATR)
- FBK 1.47
- SWTX 1.80
- MACD
- FBK -0.80
- SWTX -0.97
- Stochastic Oscillator
- FBK 9.21
- SWTX 11.69
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.